Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report)’s stock price fell 21.2% during trading on Monday. The stock traded as low as $0.2050 and last traded at $0.2050. 114 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 600 shares. The stock had previously closed at $0.26.
Zelira Therapeutics Price Performance
The company’s fifty day moving average price is $0.26 and its two-hundred day moving average price is $0.32.
About Zelira Therapeutics
Zelira Therapeutics Limited is an Australia-based biopharmaceutical company focused on developing and commercializing cannabinoid-based medicines. The company’s activities include pharmaceutical research, product formulation, clinical development and the commercialization of medicinal cannabis products for conditions such as insomnia, chronic pain and other health disorders.
Zelira has developed proprietary cannabinoid formulations and has conducted clinical studies to evaluate their safety and potential therapeutic benefits.
Further Reading
- Five stocks we like better than Zelira Therapeutics
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
